⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iii colorectal cancer ajcc v8

Every month we try and update this database with for stage iii colorectal cancer ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal CancerNCT03992456
Metastatic Colo...
Metastatic Colo...
Metastatic Rect...
Stage III Colon...
Stage III Color...
Stage III Recta...
Stage IIIA Colo...
Stage IIIA Colo...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Colo...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Colo...
Stage IIIC Rect...
Stage IV Colon ...
Stage IV Colore...
Stage IV Rectal...
Stage IVA Colon...
Stage IVA Color...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Color...
Stage IVB Recta...
Stage IVC Colon...
Stage IVC Color...
Stage IVC Recta...
Unresectable Co...
Unresectable Co...
Unresectable Re...
Panitumumab
Quality-of-Life...
Questionnaire A...
Regorafenib
Trifluridine an...
18 Years - Academic and Community Cancer Research United
Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF TrialNCT06016725
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Stage I Colorec...
Stage I Prostat...
Stage II Colore...
Stage II Prosta...
Stage III Color...
Stage III Prost...
Exercise Interv...
Informational I...
Nutritional Ass...
Physical Perfor...
Quality-of-Life...
Questionnaire A...
65 Years - Ohio State University Comprehensive Cancer Center
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesNCT04535401
Advanced Colore...
Advanced Digest...
Advanced Gastri...
Advanced Gastro...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Metastatic Colo...
Metastatic Dige...
Metastatic Gast...
Metastatic Gast...
Stage III Color...
Stage IV Colore...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Fluorouracil
Irinotecan Hydr...
Leucovorin Calc...
18 Years - National Cancer Institute (NCI)
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Patients With Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH TrialNCT04704661
Advanced Breast...
Advanced Colon ...
Advanced Colore...
Advanced Endome...
Advanced Gastri...
Advanced Gastro...
Advanced Malign...
Advanced Saliva...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
HER2-Positive B...
Malignant Hepat...
Metastatic Brea...
Metastatic Gast...
Metastatic Mali...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Colon...
Stage III Color...
Stage III Major...
Stage III Uteri...
Stage IIIA Colo...
Stage IIIA Colo...
Stage IIIA Uter...
Stage IIIB Colo...
Stage IIIB Colo...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Colo...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Colon ...
Stage IV Colore...
Stage IV Major ...
Stage IV Uterin...
Stage IVA Colon...
Stage IVA Color...
Stage IVA Major...
Stage IVA Uteri...
Stage IVB Colon...
Stage IVB Color...
Stage IVB Major...
Stage IVB Uteri...
Stage IVC Colon...
Stage IVC Color...
Stage IVC Major...
Unresectable Co...
Unresectable Ga...
Unresectable Ma...
Ceralasertib
Trastuzumab Der...
18 Years - National Cancer Institute (NCI)
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesNCT04535401
Advanced Colore...
Advanced Digest...
Advanced Gastri...
Advanced Gastro...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Metastatic Colo...
Metastatic Dige...
Metastatic Gast...
Metastatic Gast...
Stage III Color...
Stage IV Colore...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Fluorouracil
Irinotecan Hydr...
Leucovorin Calc...
18 Years - National Cancer Institute (NCI)
Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal CancersNCT03563651
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Biopsy
Biospecimen Col...
Laboratory Biom...
Questionnaire A...
18 Years - University of Southern California
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA StudyNCT04593277
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Hematopoietic a...
Invasive Malign...
Leukemia
Lymphoma
Malignant Solid...
Sarcoma
Stage I Colorec...
Stage II Colore...
Stage III Color...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Thyroid Gland C...
Internet Mobile...
Internet-Based ...
Questionnaire A...
Supportive Care
Informational I...
18 Years - Fred Hutchinson Cancer Center
Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal CancerNCT02983578
Advanced Colore...
Advanced Lung N...
Lung Non-Small ...
Mismatch Repair...
Refractory Colo...
Refractory Lung...
Refractory Panc...
Stage II Pancre...
Stage III Color...
Stage III Lung ...
Stage III Pancr...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIC Colo...
Stage IIIC Lung...
Stage IV Colore...
Stage IV Lung C...
Stage IV Pancre...
Stage IVA Color...
Stage IVA Lung ...
Stage IVB Color...
Stage IVB Lung ...
Stage IVC Color...
Danvatirsen
Durvalumab
18 Years - M.D. Anderson Cancer Center
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyNCT03707574
Advanced Malign...
Advanced Melano...
Advanced Renal ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Color...
Stage III Lung ...
Stage III Ovari...
Stage III Prost...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIC Colo...
Stage IIIC Lung...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IV Colore...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Prosta...
Stage IVA Color...
Stage IVA Lung ...
Stage IVA Ovari...
Stage IVA Prost...
Stage IVB Color...
Stage IVB Lung ...
Stage IVB Ovari...
Stage IVB Prost...
Stage IVC Color...
Biospecimen Col...
18 Years - National Cancer Institute (NCI)
CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid TumorsNCT05733000
Advanced Biliar...
Advanced Colore...
Advanced Gastro...
Advanced Lung A...
Advanced Malign...
Advanced Ovaria...
Advanced Pancre...
Advanced Urothe...
Clinical Stage ...
Clinical Stage ...
Metastatic Bili...
Metastatic Colo...
Metastatic Gast...
Metastatic Lung...
Metastatic Ovar...
Metastatic Panc...
Metastatic Urot...
Refractory Bili...
Refractory Colo...
Refractory Gast...
Refractory Lung...
Refractory Ovar...
Refractory Panc...
Refractory Urot...
Stage II Pancre...
Stage III Color...
Stage III Lung ...
Stage III Ovari...
Stage III Pancr...
Stage IV Colore...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Pancre...
Biospecimen Col...
Computed Tomogr...
Devimistat
Fluorouracil
Gemcitabine Hyd...
Hydroxychloroqu...
Magnetic Resona...
18 Years - Northwestern University
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal CancerNCT04511039
Advanced Malign...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Metastatic Colo...
Metastatic Gast...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Trifluridine an...
Talazoparib Tos...
18 Years - Roswell Park Cancer Institute
Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and IntestinesNCT04535401
Advanced Colore...
Advanced Digest...
Advanced Gastri...
Advanced Gastro...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Metastatic Colo...
Metastatic Dige...
Metastatic Gast...
Metastatic Gast...
Stage III Color...
Stage IV Colore...
Biopsy
Biospecimen Col...
Diagnostic Imag...
Elimusertib
Fluorouracil
Irinotecan Hydr...
Leucovorin Calc...
18 Years - National Cancer Institute (NCI)
Real-Time Monitoring of Chemotherapy Side-Effects in Patients With Gastrointestinal Cancers, RT-CAMSS StudyNCT04449679
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Stage 0 Colorec...
Stage 0 Pancrea...
Stage I Colorec...
Stage I Pancrea...
Stage IA Pancre...
Stage IB Pancre...
Stage II Colore...
Stage II Pancre...
Stage IIA Color...
Stage IIA Pancr...
Stage IIB Color...
Stage IIB Pancr...
Stage IIC Color...
Stage III Color...
Stage III Pancr...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IV Pancre...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Patient Monitor...
Questionnaire A...
Consultation
18 Years - Thomas Jefferson University
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and EffectivenessNCT05691491
Advanced Malign...
Advanced Micros...
Hematopoietic a...
Metastatic Mali...
Metastatic Micr...
Stage III Color...
Stage IV Colore...
Biopsy
Biospecimen Col...
Computed Tomogr...
Magnetic Resona...
Temozolomide
Tuvusertib
18 Years - National Cancer Institute (NCI)
EXERCISING TOGETHER for Couples Coping With CancerNCT03630354
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Breast Carcinom...
Colorectal Carc...
Malignant Solid...
Prostate Carcin...
Stage I Colorec...
Stage I Prostat...
Stage II Colore...
Stage II Prosta...
Stage III Color...
Stage III Prost...
Exercise Interv...
Exercise Interv...
Informational I...
Questionnaire A...
35 Years - 80 YearsOHSU Knight Cancer Institute
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal CancerNCT04017650
BRAF NP_004324....
Metastatic Colo...
Metastatic Micr...
Metastatic Rect...
Progressive Dis...
Recurrent Color...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Unresectable Co...
Unresectable Re...
Cetuximab
Encorafenib
Nivolumab
18 Years - M.D. Anderson Cancer Center
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal CancerNCT04137107
Stage II Colore...
Stage III Color...
Oxaliplatin
Duloxetine Hydr...
Duloxetine
Quality-of-Life...
Questionnaire A...
Placebo
25 Years - Alliance for Clinical Trials in Oncology
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal CancerNCT04017650
BRAF NP_004324....
Metastatic Colo...
Metastatic Micr...
Metastatic Rect...
Progressive Dis...
Recurrent Color...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Unresectable Co...
Unresectable Re...
Cetuximab
Encorafenib
Nivolumab
18 Years - M.D. Anderson Cancer Center
Pilot Trial of Resistant Starch in Stage I-III Colorectal Cancer SurvivorsNCT03781778
Colon Cancer
Rectal Cancer
Cancer Survivor
Colorectal Aden...
Stage I Colorec...
Stage II Colore...
Stage IIA Color...
Stage IIB Color...
Stage IIC Color...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Dietary Interve...
Dietary Interve...
Questionnaire A...
18 Years - Fred Hutchinson Cancer Center
Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR AlterationsNCT04096417
FGFR1 Gene Ampl...
FGFR1 Gene Muta...
FGFR1 Gene Tran...
FGFR2 Gene Ampl...
FGFR2 Gene Muta...
FGFR2 Gene Tran...
FGFR3 Gene Ampl...
FGFR3 Gene Muta...
FGFR3 Gene Tran...
Metastatic Colo...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Unresectable Co...
Pemigatinib
Quality-of-Life...
18 Years - Academic and Community Cancer Research United
Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF TrialNCT06016725
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Stage I Colorec...
Stage I Prostat...
Stage II Colore...
Stage II Prosta...
Stage III Color...
Stage III Prost...
Exercise Interv...
Informational I...
Nutritional Ass...
Physical Perfor...
Quality-of-Life...
Questionnaire A...
65 Years - Ohio State University Comprehensive Cancer Center
Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal CancerNCT03844620
Refractory Colo...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Best Practice
Laboratory Proc...
Quality-of-Life...
Questionnaire A...
Regorafenib
Trifluridine an...
18 Years - M.D. Anderson Cancer Center
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesNCT04501913
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Hepatobiliary N...
Malignant Diges...
Malignant Femal...
Malignant Genit...
Malignant Neopl...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage 0 Colorec...
Stage 0a Bladde...
Stage 0is Bladd...
Stage I Bladder...
Stage I Cervica...
Stage I Colorec...
Stage I Ovarian...
Stage I Prostat...
Stage I Renal C...
Stage I Uterine...
Stage IA Cervic...
Stage IA Ovaria...
Stage IA Uterin...
Stage IA1 Cervi...
Stage IA2 Cervi...
Stage IB Cervic...
Stage IB Ovaria...
Stage IB Uterin...
Stage IB1 Cervi...
Stage IB2 Cervi...
Stage IC Ovaria...
Stage II Bladde...
Stage II Cervic...
Stage II Colore...
Stage II Ovaria...
Stage II Prosta...
Stage II Renal ...
Stage II Uterin...
Stage IIA Cervi...
Stage IIA Color...
Stage IIA Ovari...
Stage IIA Prost...
Stage IIA1 Cerv...
Stage IIA2 Cerv...
Stage IIB Cervi...
Stage IIB Color...
Stage IIB Ovari...
Stage IIB Prost...
Stage IIC Color...
Stage IIC Prost...
Stage III Bladd...
Stage III Cervi...
Stage III Color...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Blad...
Stage IIIA Cerv...
Stage IIIA Colo...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIA Uter...
Stage IIIA1 Ova...
Stage IIIA2 Ova...
Stage IIIB Blad...
Stage IIIB Cerv...
Stage IIIB Colo...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IIIC Uter...
Stage IIIC1 Ute...
Stage IIIC2 Ute...
Stage IV Bladde...
Stage IV Cervic...
Stage IV Colore...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Bladd...
Stage IVA Cervi...
Stage IVA Color...
Stage IVA Ovari...
Stage IVA Prost...
Stage IVA Uteri...
Stage IVB Bladd...
Stage IVB Cervi...
Stage IVB Color...
Stage IVB Ovari...
Stage IVB Prost...
Stage IVB Uteri...
Stage IVC Color...
Patient Monitor...
Questionnaire A...
18 Years - City of Hope Medical Center
Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal CancerNCT04511039
Advanced Malign...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Clinical Stage ...
Locally Advance...
Locally Advance...
Metastatic Colo...
Metastatic Gast...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Postneoadjuvant...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Trifluridine an...
Talazoparib Tos...
18 Years - Roswell Park Cancer Institute
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer SurvivorsNCT05930496
Stage II Colore...
Stage III Color...
Biospecimen Col...
Exercise Interv...
Exercise Interv...
Health Educatio...
Interview
Questionnaire A...
18 Years - 70 YearsFred Hutchinson Cancer Center
Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV CancerNCT04067960
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Anatomic Stage ...
Biliary Tract C...
Clinical Stage ...
Clinical Stage ...
Malignant Brain...
Malignant Genit...
Malignant Solid...
Pancreatobiliar...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Pathologic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Prognostic Stag...
Stage III Color...
Stage III Ovari...
Stage III Pancr...
Stage III Prost...
Stage IIIA Colo...
Stage IIIA Ovar...
Stage IIIA Pros...
Stage IIIB Colo...
Stage IIIB Ovar...
Stage IIIB Pros...
Stage IIIC Colo...
Stage IIIC Ovar...
Stage IIIC Pros...
Stage IV Colore...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Prosta...
Stage IVA Color...
Stage IVA Ovari...
Stage IVA Pancr...
Stage IVA Prost...
Stage IVB Color...
Stage IVB Ovari...
Stage IVB Pancr...
Stage IVB Prost...
Stage IVC Color...
Biospecimen Col...
Genetic Testing
Quality-of-Life...
Questionnaire A...
- Mayo Clinic
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal CancerNCT04017650
BRAF NP_004324....
Metastatic Colo...
Metastatic Micr...
Metastatic Rect...
Progressive Dis...
Recurrent Color...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Unresectable Co...
Unresectable Re...
Cetuximab
Encorafenib
Nivolumab
18 Years - M.D. Anderson Cancer Center
Collection of Blood, Urine, and Stool to Monitor MetastaticColorectal CancersNCT03563651
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Biopsy
Biospecimen Col...
Laboratory Biom...
Questionnaire A...
18 Years - University of Southern California
TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO StudyNCT04109924
Advanced Colore...
Metastatic Colo...
Metastatic Rect...
Recurrent Colon...
Recurrent Color...
Recurrent Recta...
Stage III Colon...
Stage III Color...
Stage III Recta...
Stage IIIA Colo...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Colo...
Stage IV Colon ...
Stage IVA Color...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Color...
Stage IVB Recta...
Stage IVC Colon...
Stage IVC Color...
Stage IVC Recta...
Unresectable Co...
Unresectable Co...
Unresectable Re...
Irinotecan
Bevacizumab
Trifluridine an...
18 Years - Roswell Park Cancer Institute
Pembrolizumab and Autologous Dendritic Cells for the Treatment of Refractory Colorectal Cancer (CRC)NCT05518032
Metastatic Micr...
Recurrent Color...
Stage III Color...
Stage IV Colore...
Unresectable Co...
Biopsy
Pembrolizumab
Therapeutic Aut...
18 Years - Roswell Park Cancer Institute
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryNCT02595931
Metastatic Colo...
Metastatic Lung...
Metastatic Mali...
Metastatic Panc...
Refractory Colo...
Refractory Lung...
Refractory Mali...
Refractory Panc...
Stage III Color...
Stage III Lung ...
Stage III Pancr...
Stage IV Colore...
Stage IV Lung C...
Stage IV Pancre...
Unresectable Co...
Unresectable Lu...
Unresectable Ma...
Unresectable Pa...
Berzosertib
Biopsy Specimen
Biospecimen Col...
Computed Tomogr...
Irinotecan Hydr...
18 Years - National Cancer Institute (NCI)
Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal CancerNCT04117945
BRAF V600E Nega...
KRAS Gene Mutat...
Locally Advance...
Metastatic Colo...
NRAS Gene Mutat...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Cetuximab
Irinotecan
Panitumumab
Regorafenib
18 Years - Academic and Community Cancer Research United
Patient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsNCT03867916
Caregiver
Malignant Neopl...
Physician
Stage I Colorec...
Stage I Liver C...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Colore...
Stage II Liver ...
Stage II Lung C...
Stage IIA Color...
Stage IIA Lung ...
Stage IIB Color...
Stage IIB Lung ...
Stage IIC Color...
Stage III Color...
Stage III Liver...
Stage III Lung ...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIC Colo...
Stage IIIC Lung...
Patient Navigat...
Quality-of-Life...
Survey Administ...
21 Years - University of California, San Francisco
Diet Education Program for Stage I-IV Colorectal Cancer SurvivorsNCT04597151
Stage I Colorec...
Stage II Colore...
Stage IIA Color...
Stage IIB Color...
Stage IIC Color...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Dietary Interve...
18 Years - University of California, San Francisco
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal CancerNCT04428905
Lung Non-Small ...
Stage I Colorec...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Colore...
Stage II Lung C...
Stage IIA Color...
Stage IIA Lung ...
Stage IIB Color...
Stage IIB Lung ...
Stage IIC Color...
Stage III Color...
Stage III Lung ...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIC Colo...
Stage IIIC Lung...
Quality-of-Life...
Questionnaire A...
Survivorship Ca...
Telemedicine
18 Years - City of Hope Medical Center
Rintatolimod and Pembrolizumab for the Treatment of Refractory Metastatic or Unresectable Colorectal CancerNCT04119830
Metastatic Colo...
Microsatellite ...
Mismatch Repair...
Refractory Colo...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Stage IV Colore...
Stage IVA Color...
Stage IVB Color...
Stage IVC Color...
Unresectable Co...
Pembrolizumab
Questionnaire A...
Rintatolimod
18 Years - Roswell Park Cancer Institute
Evaluating the Effects of an Exercise Intervention on the Gut Microbiota in Stage II-III Colorectal Cancer SurvivorsNCT05930496
Stage II Colore...
Stage III Color...
Biospecimen Col...
Exercise Interv...
Exercise Interv...
Health Educatio...
Interview
Questionnaire A...
18 Years - 70 YearsFred Hutchinson Cancer Center
Patient Portal and Navigation Program in Providing Information for Asian American Cancer PatientsNCT03867916
Caregiver
Malignant Neopl...
Physician
Stage I Colorec...
Stage I Liver C...
Stage I Lung Ca...
Stage IA1 Lung ...
Stage IA2 Lung ...
Stage IA3 Lung ...
Stage IB Lung C...
Stage II Colore...
Stage II Liver ...
Stage II Lung C...
Stage IIA Color...
Stage IIA Lung ...
Stage IIB Color...
Stage IIB Lung ...
Stage IIC Color...
Stage III Color...
Stage III Liver...
Stage III Lung ...
Stage IIIA Colo...
Stage IIIA Lung...
Stage IIIB Colo...
Stage IIIB Lung...
Stage IIIC Colo...
Stage IIIC Lung...
Patient Navigat...
Quality-of-Life...
Survey Administ...
21 Years - University of California, San Francisco
Systems Support Mapping in Guiding Self-Management in Stage I-III Colorectal Cancer SurvivorsNCT03520283
Cancer Survivor
Stage I Colorec...
Stage II Colore...
Stage IIA Color...
Stage IIB Color...
Stage IIC Color...
Stage III Color...
Stage IIIA Colo...
Stage IIIB Colo...
Stage IIIC Colo...
Interview
Questionnaire A...
System Support ...
18 Years - Wake Forest University Health Sciences
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: